Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital
- PMID: 32384180
- PMCID: PMC7273083
- DOI: 10.1111/ced.14277
Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital
Abstract
COVID-19 is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2). Vesicular skin rashes have been reported as associated with COVID-19, but there is little information about this cutaneous manifestation. We designed a prospective observational study of patients diagnosed with COVID-19 who had vesicular lesions. Clinical characterization of skin findings was conducted by dermatologists. When possible, histological analysis and detection of SARS-CoV-2 in the content of the vesicles was performed. In total, 24 patients were included. A disseminated pattern was found in 18 patients (75%), and a localized pattern was found in 6 (25%). Median duration of the skin rash was 10 days. Of the 24 patients, 19 (79.2%) developed the skin rash after the onset of COVID-19 symptoms. Histological examination in two patients was consistent with viral infection, SARS-CoV-2 was not detected in four patients. This single-centre study shows the clinical characteristics of vesicular skin rashes in patients with COVID-19.
© 2020 British Association of Dermatologists.
Figures

Comment in
-
Comment on 'Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital'. Pseudoherpetic Grover disease seems to occur in patients with COVID-19 infection.Clin Exp Dermatol. 2020 Oct;45(7):896-898. doi: 10.1111/ced.14305. Epub 2020 Jul 13. Clin Exp Dermatol. 2020. PMID: 32438476 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous